mlsanityData to 7 Oct 2026

APOD: reasoning-guided agentic population ordinary differential equation discovery for pharmacological digital twins

arXiv 2610.06227 ↗First posted 5 Oct 2026q-bio.QM cs.AI cs.LGcited by 0

On the map: LLM agents and tool use → Medical and scientific domain agents

Abstract (arXiv)

Establishing ordinary differential equations (ODEs) describing population data is a fundamental part of mathematical modeling in pharmacology, crucial to developing digital twins. However, doing so from sparse, noisy data is a slow, expert-driven task. Existing automated methods either search a restricted model space or ignore population inter-individual variability. Here we introduce APOD (Agentic Population ODE Discovery), a language-model agent that iteratively reasons over biological knowledge and fit diagnostics in an open-ended search space to discover a population digital twin (PDT), i.e., a shared ODE system with between-subject variability. On synthetic pharmacokinetic and tumor-dynamics benchmarks, APOD recovered ground-truth structures in 94-100% of runs, 12-fold faster in median than an established library-based search. On real cohorts it converged to valid structures, and proposed a PDT of radioligand-therapy-induced platelet dynamics that predicts thrombocytopenia from first-cycle data and simulates alternative dosing schedules that lower the predicted risk of toxicity.

Key facts. No citing papers in the map yet (data through 7 Oct 2026). Placed in Medical and scientific domain agents, one of 16 directions in LLM agents and tool use. First posted on arXiv 5 Oct 2026.

Builds on

No reference list yet.

Built on by

Not cited yet.

Similar, not cited

Close in wording, no citation either way

  1. 2026Automatic Ordinary Differential Equations Discovery For Biological Systems Using Large Language Model Powered Agentic System
  2. 2025MADD: Multi-Agent Drug Discovery Orchestra
  3. 2025LLM Agent Swarm for Hypothesis-Driven Drug Discovery
  4. 2026TxBench-PP: Analyzing AI Agent Performance on Small-Molecule Preclinical Pharmacology
  5. 2024DrugAgent: Reliable Multi-Agent Integration of Conflicting Biomedical Evidence for Drug-Target Interaction Assessment
  6. 2025AI Agents in Drug Discovery
  7. 2025MedAI: Evaluating TxAgent's Therapeutic Agentic Reasoning in the NeurIPS CURE-Bench Competition
  8. 2025TxAgent: An AI Agent for Therapeutic Reasoning Across a Universe of Tools